Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from Prograf to Advagraf in stable kidney transplant recipients
2010-019086-28Phase 4Active
- Sponsor
- UO Nefrologia, Dialisi e Trapianto renale
- Start
- Sep 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus, sponsored by UO Nefrologia, Dialisi e Trapianto renale. Primary endpoints: Stability of tacrolimus plasma levels after switch to Advagraf, Stability of renal function after switch to Advagraf and 2 more. Started Sep 2010; status: active.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on 2010-019086-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019086-28.